Literature DB >> 1328058

Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses.

R T Gazzinelli1, J W Hartley, T N Fredrickson, S K Chattopadhyay, A Sher, H C Morse.   

Abstract

Mice infected with LP-BM5 murine leukemia viruses develop a syndrome, termed mouse AIDS (MAIDS), characterized by increasingly severe immunodeficiency and progressive lymphoproliferation. Virus-infected mice were examined for the ability to resist acute infection and to control chronic infection with the protozoan Toxoplasma gondii, a major opportunistic pathogen of individuals infected with human immunodeficiency virus. Mice infected with the retroviruses for 2 or 4 weeks responded normally to challenge with the parasite, but mice inoculated with the protozoan 8 or 12 weeks after viral infection died with acute disease due to T. gondii. Increased sensitivity to acute infection was associated with a reduced ability to produce gamma interferon (IFN-gamma) and with established changes in CD4+ T-cell function. Mice latently infected with T. gondii and then inoculated with the retrovirus mixture were found to reactivate the parasite infection, with 30 to 40% of dually infected animals dying between 5 and 16 weeks after viral infection. Reactivation was associated with reduced proliferation and impaired production of IFN-gamma in response to stimulation with soluble T. gondii antigens or to concanavalin A. Continuing resistance to lethal reactivation in the remaining mice was shown to require CD8+ T cells and expression of IFN-gamma. In addition, it was found that chronic infection with T. gondii altered the course of MAIDS by inhibiting the progression of splenomegaly and immunodeficiency and reducing the expression of both the helper and etiologic defective viruses. These results support previous studies which indicate that infection with T. gondii is controlled by synergistic interactions between CD4+ and CD8+ T cells, the functions of which are progressively impaired during the course of MAIDS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328058      PMCID: PMC257477          DOI: 10.1128/iai.60.10.4394-4401.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitis.

Authors:  D M Israelski; F G Araujo; F K Conley; Y Suzuki; S Sharma; J S Remington
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

2.  Toxoplasma peritonitis in a patient with acquired immunodeficiency syndrome.

Authors:  D M Israelski; G Skowron; J P Leventhal; I Long; C F Blankenship; G W Barrio; J B Prince; F G Araujo; J S Remington
Journal:  Arch Intern Med       Date:  1988-07

3.  Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.

Authors:  Y Suzuki; F K Conley; J S Remington
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

4.  Severe immunodeficiency disease induced by a defective murine leukaemia virus.

Authors:  D C Aziz; Z Hanna; P Jolicoeur
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

5.  Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains.

Authors:  J W Hartley; T N Fredrickson; R A Yetter; M Makino; H C Morse
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  Reactivation of Toxoplasma gondii by cytomegalovirus disease in mice: antimicrobial activities of macrophages.

Authors:  C Pomeroy; S Kline; M C Jordan; G A Filice
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

7.  Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells.

Authors:  R M Buller; K L Holmes; A Hügin; T N Frederickson; H C Morse
Journal:  Nature       Date:  1987 Jul 2-8       Impact factor: 49.962

8.  Diffuse toxoplasmic retinochoroiditis in a patient with AIDS.

Authors:  D W Parke; R L Font
Journal:  Arch Ophthalmol       Date:  1986-04

9.  CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS).

Authors:  R A Yetter; R M Buller; J S Lee; K L Elkins; D E Mosier; T N Fredrickson; H C Morse
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.

Authors:  D E Mosier; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more
  20 in total

1.  Changes in cytokine levels during reactivation of Toxoplasma gondii infection in lungs.

Authors:  G A Filice; C R Clabots; P E Riciputi; O Goñi-Laguardia; C Pomeroy
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.

Authors:  N A Giese; R T Gazzinelli; J K Actor; R A Morawetz; M Sarzotti; H C Morse
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

3.  Coinfection with Toxoplasma gondii inhibits antigen-specific Th2 immune responses, tissue inflammation, and parasitism in BALB/c mice infected with Leishmania major.

Authors:  H C Santiago; M A Oliveira; E A Bambirra; A M Faria; L C Afonso; L Q Vieira; R T Gazzinelli
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Th0-like CD4+ T cells protect mice with murine retrovirus-induced immunodeficiency syndrome (MAIDS) against co-infection with Listeria monocytogenes.

Authors:  K Hiromatsu; H Nishimura; K Kimura; Y Aoki; J Usami; N Kobayashi; M Makino; Y Yoshikai
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

5.  Immune CD8(+) T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host.

Authors:  I A Khan; W R Green; L H Kasper; K A Green; J D Schwartzman
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Citrobacter-induced colitis in mice with murine acquired immunodeficiency syndrome.

Authors:  T N Fredrickson; J W Hartley; H C Morse
Journal:  Vet Pathol       Date:  2010-01-29       Impact factor: 2.221

7.  Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis.

Authors:  M G Davidson; J B Rottman; R V English; M R Lappin; M B Tompkins
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

8.  Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS).

Authors:  C Lacroix; F Chau; C Carbon; M Sinet; F Derouin
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

9.  Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology.

Authors:  M Eckwalanga; M Marussig; M D Tavares; J C Bouanga; E Hulier; J H Pavlovitch; P Minoprio; D Portnoï; L Rénia; D Mazier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

10.  Effects of exogenous, nonleukemogenic, ecotropic murine leukemia virus infections on the immune systems of adult C57BL/6 mice.

Authors:  J S Lee; N A Giese; K L Elkins; R A Yetter; K L Holmes; J W Hartley; H C Morse
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.